Clinical Evaluation of the FilmArray® Global Fever (GF) Panel
NCT02968355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2084
Last updated 2024-07-05
Summary
This study will evaluate the clinical sensitivity and specificity of the FilmArray Global Fever (GF) Panel.
Conditions
Interventions
- OTHER
-
Observational study
Observational study
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
BioFire Defense LLC
lead INDUSTRY
Principal Investigators
-
Cynthia Phillips, Ph. D. · BioFire Defense LLC
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-26
- Primary Completion
- 2021-03-30
- Completion
- 2021-03-30
Countries
- United States
- Cambodia
- Georgia
- Ghana
- Honduras
- Kenya
- Peru
- Tanzania
- Thailand
- Uganda
Study Locations
More Related Trials
-
Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)
NCT01921413 ·Status: COMPLETED
-
Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection
NCT02098590 ·Status: COMPLETED ·Phase: NA
-
Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali
NCT05135273 ·Status: COMPLETED ·Phase: PHASE1
-
Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children
NCT00360230 ·Status: COMPLETED ·Phase: PHASE2
-
Host Response to Infection and Treatment in Lymphatic Filarial Disease in India
NCT00342576 ·Status: COMPLETED
-
Characterizing Humoral Immune Response to Mosquito Bites
NCT04478370 ·Status: COMPLETED ·Phase: NA
-
Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults
NCT06507605 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers
NCT00332956 ·Status: COMPLETED ·Phase: PHASE2
-
Pan-Malaria Transmission-Blocking Vaccine AnAPN1
NCT05905432 ·Status: COMPLETED ·Phase: PHASE1
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Testing a Biometric Identification System to Improve Malaria Vaccine Completion
NCT07261280 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel
NCT03895281 ·Status: UNKNOWN
-
Biological Mechanisms in Afebrile P. Falciparum Malaria
NCT04422015 ·Status: COMPLETED
-
Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults
NCT01988636 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B
NCT02458092 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity
NCT01160562 ·Status: COMPLETED
-
Fever After Tick Bite Study
NCT03932448 ·Status: WITHDRAWN
-
Diagnosis and Treatment of Leishmania Infections
NCT00344188 ·Status: RECRUITING
-
Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso
NCT01018459 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites
NCT03168854 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model
NCT04072302 ·Status: COMPLETED ·Phase: PHASE1
-
L9LS in Women of Childbearing Potential in Mali
NCT07060508 ·Status: RECRUITING ·Phase: PHASE2
-
Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea
NCT03590340 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
NCT02942277 ·Status: COMPLETED ·Phase: PHASE1